Cite
APA Citation
Chorzalska, A., Ahsan, N., Rao, R. S. P., Roder, K., Yu, X., Morgan, J., Tepper, A., Hines, S., Zhang, P., Treaba, D. O., Zhao, T. C., Olszewski, A. J., Reagan, J. L., Liang, O., Gruppuso, P. A., & Dubielecka, P. M. (2018). overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia. Molecular oncology, 12(5), 630–647. http://access.bl.uk/ark:/81055/vdc_100063822715.0x000009